The report retains BUY with TP of INR2,580 premised on Organolithium and electrolyte business growth, despite Q2 EBITDA/APAT coming below estimates.
Read this note →Neogen Chemicals Limited
NSE NEOGEN BSE 542665 INE136S01016
0 filings · 0 analysed
2,665.20
+53.08%
over 6 months
-
HSIE Results Daily 03 Nov 26 HSIE
The report retains BUY with TP of INR2,580 premised on Organolithium and electrolyte business growth, despite Q2 EBITDA/APAT coming below estimates.
-
The report recommends a BUY rating with a target of ₹2,765 (20x FY28E EBITDA), citing battery-materials capex and strategic tie-ups with Mitsubishi and Morita.
-
Chemicals Q2FY27 Results Preview HSIE
The report expects APAT to rise sharply YoY and the rating was revised down from BUY to REDUCE with a raised target price.
-
SHORT TERM PICK - Buy Neogen Chemicals Ltd
The note says Neogen may be bought in the 2380-2410 range (CMP 2380.20, add on dip at 2295) with a stop loss of 2260 and a target of 2550 over up to 10 days, citing support near the 20 DEMA and a bounce, a volume jump on intraday charts, a bullish RSI setup on the hourly chart and a higher top/higher bottom formation on hourly charts.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 03 Nov 2026, 06:38 | long | 2,095.40 | 2,580.00 | 2,548.60 | 94% | hit |
| ICICI Securities Ltd. (Retail Equity Research) / ICICI Direct | 02 Nov 2026, 17:02 | long | 2,095.40 | 2,765.00 | 2,548.60 | 68% | open by 2027-11-02 |
| HDFC Securities | 14 Oct 2026, 15:45 | short | 2,687.90 | 2,603.00 | 2,173.70 | 200% | hit |
| HDFC Securities | 11 Sep 2026, 13:40 | long | 2,373.00 | 2,550.00 | 2,173.70 | -100% | hit |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report recommends a BUY rating with a target of ₹2,765 (20x FY28E EBITDA), citing battery-materials capex and strategic tie-ups with Mitsubishi and Morita.
Read this note →The report expects APAT to rise sharply YoY and the rating was revised down from BUY to REDUCE with a raised target price.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief